Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging
Zehua Zhu, Zhaojun Chen, Mingxing Wang, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Exosomal Cargo in Ovarian Cancer Dissemination
Ekaterina Dzhugashvili, С. Н. Тамкович
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9851-9867
Open Access | Times Cited: 5
The role of tumor-educated platelets in ovarian cancer: A comprehensive review and update
Dimple Patel, Sanu Thankachan, Saraswathy Sreeram, et al.
Pathology - Research and Practice (2022) Vol. 241, pp. 154267-154267
Closed Access | Times Cited: 8
Role of Exosomal miR-205-5p Cargo in Angiogenesis and Cell Migration
Miriam Martínez-Santos, María Ybarra, María Rosa Oltra, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 934-934
Open Access | Times Cited: 1
Nanoparticles for Imaging of Lymphatic System: Challenges and Future Perspective
Hope Onohuean, Nnamdi Ikemefuna Okafor, Yahya E. Choonara
(2024), pp. 311-335
Closed Access | Times Cited: 1
Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis
Apriliana E. R. Kartikasari, Paul Michel-Lara, Hayden Exton, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4190-4190
Open Access | Times Cited: 1
Exosomes in the f ield of reproduction: A scientometric study and visualization analysis
Yifeng Shen, Yaodong You, Kun Zhu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer
Aleksandra Englisz, Marta Smycz‐Kubańska, Aleksandra Mielczarek‐Palacz
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1714-1714
Open Access | Times Cited: 3
“Silicon-On-Insulator”-Based Biosensor for the Detection of MicroRNA Markers of Ovarian Cancer
Yuri D. Ivanov, Svetlana I. Kapustina, Kristina A. Malsagova, et al.
Micromachines (2022) Vol. 14, Iss. 1, pp. 70-70
Open Access | Times Cited: 5
Advances in Exosomes as Diagnostic and Therapeutic Biomarkers for Gynaecological Malignancies
Mengdan Miao, Yifei Miao, Yanping Zhu, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4743-4743
Open Access | Times Cited: 5
“DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
Jacek R. Wilczyński, Miłosz Wilczyński, Edyta Paradowska
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients
Patrick H D Petersen, Joanna Lopacinska‐Jørgensen, Claus Høgdall, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 12, pp. 10235-10247
Open Access | Times Cited: 2
Insight on Non-Coding RNAs from Biofluids in Ovarian Tumors
Yohann Dabi, Amélia Favier, Léo Razakamanantsoa, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1539-1539
Open Access | Times Cited: 1
Clinical Application of Small Extracellular Vesicles in Gynecologic Malignancy Treatments
Fei Zheng, Jiao Wang, Dandan Wang, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1984-1984
Open Access | Times Cited: 1
An Early Detection of Ovarian Cancer and The Accurate Spreading Range in Human Body by using Deep Medical Learning Model
V. Saravanan, Veeramalai Sankaradass, M Shanmathi, et al.
(2023), pp. 68-72
Closed Access | Times Cited: 1
Liquid biopsy in ovarian cancer in China and the world: current status and future perspectives
Hui Zhang, Lingxia Wang, Huanwen Wu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers
XU Chang-fen, Peiyao Xu, Jiaqi Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Cross-sectional study on the diagnostic significance of plasma exosomal miRNAs in HBV-related hepatocellular carcinoma
Xiaoyuan Hu, Fa Huang, Jiyou Yao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Exosomal signaling in gynecologic cancer development: The role of cancer-associated fibroblasts
Mohamed J. Saadh, Omer Qutaiba B. Allela, Radhwan Abdul Kareem, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155766-155766
Closed Access
Advances in biomarker discovery and radiological techniques for early detection of ovarian cancer
A. Alkhalaf, Sulaiman Ali Alkhareeb, Bushra Mana Alshammari, et al.
International Journal of Health Sciences (2022) Vol. 6, Iss. S10, pp. 1614-1631
Open Access | Times Cited: 2
The Progress of the Specific and Rapid Genetic Detection Methods for Ovarian Cancer Diagnosis and Treatment
Kejun Dong, Wei Zhang, Shuangshuang Cheng, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21, pp. 153303382211144-153303382211144
Open Access | Times Cited: 1
The RNA content of extracellular vesicles fromPRPF31+/−hiPSC-RPE show potential as biomarkers of retinal degeneration
Heran Getachew, Sudeep Mehrotra, Tarandeep Kaur, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Previous Page - Page 2

Scroll to top